We are live on
!
Find out more
BMO
Beck Mack & Oliver Portfolio holdings
AUM
$4.85B
1-Year Est. Return
9.66%
This Fund
S&P 500
This Quarter
Est. Return
+7.71%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$5.4B
AUM Growth
+$262M
(+5.1%)
Cap. Flow
-$15.9M
Cap. Flow
% of AUM
-0.29%
Top 10 Holdings %
Top 10 Hldgs %
47.35%
Holding
199
New
22
Increased
52
Reduced
70
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CoStar Group
CSGP
|
+$43.2M |
| 2 |
Ferguson
FERG
|
+$11.5M |
| 3 |
Smith Douglas Homes
SDHC
|
+$8.54M |
| 4 |
Matador Resources
MTDR
|
+$5.05M |
| 5 |
Roper Technologies
ROP
|
+$3.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enterprise Products Partners
EPD
|
+$35.3M |
| 2 |
Apollo Global Management
APO
|
+$18.4M |
| 3 |
RadNet
RDNT
|
+$9.55M |
| 4 |
Sherwin-Williams
SHW
|
+$8.93M |
| 5 |
ESGR
Enstar Group
ESGR
|
+$8.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 43.35% |
| 2 | Healthcare | 13.58% |
| 3 | Technology | 11.42% |
| 4 | Industrials | 7.55% |
| 5 | Communication Services | 7.45% |
Similar funds
SCA
MCCA
AC
TPCW
DGI
JSTA
PBA
KCM
Beck Mack & Oliver's Q4 2024 Portfolio in Review
As of Q4 2024, Beck Mack & Oliver held 199 positions worth $5.4B, up 5.1% from $5.14B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Beck Mack & Oliver's Q4 2024 filing shows 22 new, 52 increased, 70 reduced and 9 closed positions. Its largest new stake was Oracle: 4,017 shares worth $669K. The largest sale was Enterprise Products Partners, an estimated $35.3M.
By sector, the portfolio is most concentrated in Financials at 43% of assets, up from 41% a quarter earlier, followed by Healthcare and Technology.
- Beck Mack & Oliver's largest Q4 2024 buy was Oracle: 4,017 shares worth $669K.
- Beck Mack & Oliver added most to CoStar Group in Q4 2024, an estimated $43.2M increase.
- Beck Mack & Oliver's biggest Q4 2024 reduction was Enterprise Products Partners, cutting an estimated $35.3M.
- Beck Mack & Oliver fully exited Boston Scientific in Q4 2024, selling an estimated $421K.
- Beck Mack & Oliver's ten largest holdings make up 47% of its $5.4B portfolio in Q4 2024.
- Beck Mack & Oliver opened 22 new positions and closed 9 in Q4 2024.
- Beck Mack & Oliver's portfolio value rose 5.1% quarter-over-quarter to $5.4B.
Based on Beck Mack & Oliver's 13F filing for Q4 2024, filed 13 Feb 2025.